Drug Type Small molecule drug |
Synonyms C9orf72 protein inhibitor(Libra Therapeutics) |
Target |
Action inhibitors |
Mechanism C9orf72 gene inhibitors(C9orf72-SMCR8 complex subunit gene inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neurodegenerative Diseases | Preclinical | United States | 01 Aug 2025 |





